Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lanvin Group | LANV | Nov 27, 2024 | 1.56 | +0.65 |
Lanzatech Global | LNZA | Nov 27, 2024 | 1.17 | +17.00 |
Largecap Core Alphadex First Trust | FEX | Nov 27, 2024 | 112.49 | -0.14 |
Largecap Dividend Wisdomtree | DLN | Nov 27, 2024 | 81.83 | -0.06 |
Largecap ETF Vanguard | VV | Nov 27, 2024 | 275.61 | -0.38 |
Largecap Growth Opp Alphadex First Trust | FTC | Nov 27, 2024 | 147.43 | -0.06 |
Largecap Value Opp Alphadex First Trust | FTA | Nov 27, 2024 | 83.19 | +0.12 |
Largo | LGO | Nov 27, 2024 | 2.10 | -3.23 |
Larimar Therapeutics | LRMR | Nov 27, 2024 | 6.64 | +7.44 |
Las Vegas Sands | LVS | Nov 27, 2024 | 51.42 | +0.98 |
Laser Photonics | LASE | Nov 27, 2024 | 5.61 | -6.97 |
Latham Group | SWIM | Nov 27, 2024 | 6.59 | -1.05 |
Latin America Alphadex First Trust | FLN | Nov 27, 2024 | 16.37 | -2.00 |
Lattice Semiconductor | LSCC | Nov 27, 2024 | 56.32 | +0.61 |
Launch One Acquisition | LPAA | Nov 27, 2024 | 10.01 | 0.00 |
Launch One Acquisition | LPAAU | Nov 27, 2024 | 10.06 | +0.00 |
Launch Two Acquisition Units | LPBBU | Nov 27, 2024 | 10.01 | 0.00 |
Laureate Education | LAUR | Nov 27, 2024 | 18.93 | -1.05 |
LAVA Therapeutics | LVTX | Nov 27, 2024 | 1.60 | +3.23 |
Lavoro | LVRO | Nov 27, 2024 | 4.90 | +4.03 |
Lazard A | LAZ | Nov 27, 2024 | 57.72 | -0.76 |
Lazard Global Total Return and Income Fund | LGI | Nov 27, 2024 | 16.63 | -0.06 |
Lazydays | GORV | Nov 27, 2024 | 1.00 | -0.99 |
LCI Industries | LCII | Nov 27, 2024 | 122.50 | -0.55 |
LCNB | LCNB | Nov 27, 2024 | 17.38 | +0.64 |
Lead Real Estate ADR | LRE | Nov 27, 2024 | 2.35 | +0.67 |
Leafly | LFLY | Nov 27, 2024 | 1.51 | +1.68 |
Leap Therapeutics | LPTX | Nov 27, 2024 | 2.92 | +10.19 |
Lear | LEA | Nov 27, 2024 | 97.25 | +0.46 |
LeddarTech | LDTC | Nov 27, 2024 | 0.27 | -15.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.